Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-21-015129
Filing Date
2021-03-12
Accepted
2021-03-12 16:22:30
Documents
4

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea137330-s3_immunebioinc.htm S-3 182533
2 OPINION OF SICHENZIA ROSS FERENCE LLP ea137330ex5-1_immunebio.htm EX-5.1 18357
3 CONSENT OF MARCUM LLP ea137330ex23-1_immunebio.htm EX-23.1 2070
4 GRAPHIC ex5-1_001.jpg GRAPHIC 12348
  Complete submission text file 0001213900-21-015129.txt   221098
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-254221 | Film No.: 21737722
SIC: 2836 Biological Products, (No Diagnostic Substances)